Evoke Pharma Inc logo

Evoke Pharma Inc

1
1
NAS:EVOK (USA)  
$ 4.90 -0.06 (-1.21%) 11:08 PM EST
At Loss
P/B:
1.00
Enterprise V:
$ 942.00K
Volume:
8.76K
Avg Vol (2M):
578.38K
Trade In:
Volume:
8.76K
At Loss
Avg Vol (2M):
578.38K

Business Description

Description
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
Name Current Vs Industry Vs History
Cash-To-Debt 2.27
Equity-to-Asset 0.31
Debt-to-Equity 1.14
Debt-to-EBITDA -0.89
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -12.52
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 55.08
9-Day RSI 55.8
14-Day RSI 53.71
6-1 Month Momentum % -35.68
12-1 Month Momentum % -68.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.44
Quick Ratio 1.39
Cash Ratio 1.16
Days Inventory 644.67
Days Sales Outstanding 62.57
Days Payable 2477.93

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.6
Shareholder Yield % -108.43

Financials (Next Earnings Date:2025-03-14 Est.)

EVOK's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:EVOK

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Evoke Pharma Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 8.616
EPS (TTM) ($) -11.03
Beta -0.37
Volatility % 62.99
14-Day RSI 53.71
14-Day ATR ($) 0.420855
20-Day SMA ($) 4.49498
12-1 Month Momentum % -68.62
52-Week Range ($) 3.54 - 14.0388
Shares Outstanding (Mil) 1.49

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Evoke Pharma Inc Filings

Filing Date Document Date Form
No Filing Data

Evoke Pharma Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Evoke Pharma Inc Frequently Asked Questions

What is Evoke Pharma Inc(EVOK)'s stock price today?
The current price of EVOK is $4.90. The 52 week high of EVOK is $14.04 and 52 week low is $3.54.
When is next earnings date of Evoke Pharma Inc(EVOK)?
The next earnings date of Evoke Pharma Inc(EVOK) is 2025-03-14 Est..
Does Evoke Pharma Inc(EVOK) pay dividends? If so, how much?
Evoke Pharma Inc(EVOK) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1